Costello Michael F, Emerson Sandra, Lukic Julie, Sjoblom Peter, Garrett Don, Hughes Graeme, Steigrad Stephen
Department of Reproductive Medicine and IVF Australia, Royal Hospital for Women, Randwick, Sydney, New South Wales, Australia.
Aust N Z J Obstet Gynaecol. 2004 Feb;44(1):51-6. doi: 10.1111/j.1479-828X.2004.00160.x.
There is no published data assessing whether higher mid luteal serum progesterone (P4) levels are associated with a higher cycle pregnancy rate (CPR) in controlled ovarian hyperstimulation (COH) with intrauterine insemination (IUI).
To assess whether the mid luteal serum P4 level is predictive of pregnancy in COH with IUI.
A retrospective cohort study of all women with unexplained, minimal endometriosis or mild male factor infertility who underwent COH with IUI between October 1999 and December 2000 at our department was analysed. The COH was achieved with follicle stimulating hormone injections. All cycles were triggered with human chorionic gonadotropin when at least one follicle > or =15 mm was visible on ultrasound and IUI performed the following day. A serum P4 and beta human chorionic gonadotropin level was measured at 7 and 14 days post-trigger, respectively.
There were 33 pregnancies in the 188 cycles analysed, giving a CPR of 18%. The median (range) mid luteal P4 level for all cycles was 51 nmol/L (1.8-234). This did not differ between the pregnant (55 nmol/L) and non-pregnant (50 nmol/L) cycles (P=0.282, Mann-Whitney U-test). There was also no difference in CPR between cohorts below or above the cut-off levels of 33 nmol/L (25th percentile) (13.3 vs 18.9%; P=0.39), 51 nmol/L (50th percentile) (16.0 vs 19.1%; P=0.57), or 69 nmol/L (75th percentile) (16.3 vs 21.3%; P=0.44), respectively.
Increased mid luteal serum P4 levels are not associated with a higher CPR in women undergoing COH with IUI. However, a low mid luteal P4 level < or =25 nmol/L may help predict treatment failure.
尚无已发表的数据评估在控制性卵巢过度刺激(COH)联合宫腔内人工授精(IUI)时,黄体中期血清孕酮(P4)水平升高是否与更高的周期妊娠率(CPR)相关。
评估黄体中期血清P4水平是否可预测COH联合IUI时的妊娠情况。
对1999年10月至2000年12月在我科接受COH联合IUI的所有不明原因、轻度子宫内膜异位症或轻度男性因素不孕的女性进行回顾性队列研究。通过注射促卵泡激素实现COH。当超声显示至少有一个卵泡≥15 mm时,所有周期均用人绒毛膜促性腺激素触发,并于次日进行IUI。分别在触发后7天和14天测量血清P4和β人绒毛膜促性腺激素水平。
在分析的188个周期中有33例妊娠,CPR为18%。所有周期黄体中期P4水平的中位数(范围)为51 nmol/L(1.8 - 234)。妊娠周期(55 nmol/L)和未妊娠周期(50 nmol/L)之间无差异(P = 0.282,曼-惠特尼U检验)。在低于或高于33 nmol/L(第25百分位数)(13.3%对18.9%;P = 0.39)、51 nmol/L(第50百分位数)(16.0%对19.1%;P = 0.57)或69 nmol/L(第75百分位数)(16.3%对21.3%;P = 0.44)截断水平的队列之间,CPR也无差异。
在接受COH联合IUI的女性中,黄体中期血清P4水平升高与更高的CPR无关。然而,黄体中期P4水平≤25 nmol/L可能有助于预测治疗失败。